Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Non-cash Items (2016 - 2025)

Pharma-Bio Serv (PBSV) has disclosed Non-cash Items for 13 consecutive years, with $4000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-cash Items fell 98.76% year-over-year to $4000.0, compared with a TTM value of $4000.0 through Oct 2025, down 98.76%, and an annual FY2025 reading of $4000.0, down 98.76% over the prior year.
  • Non-cash Items was $4000.0 for Q4 2025 at Pharma-Bio Serv, down from $323370.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $400000.0 in Q4 2022 and bottomed at $4000.0 in Q4 2025.
  • Average Non-cash Items over 5 years is $212960.0, with a median of $263330.0 recorded in 2023.
  • The sharpest move saw Non-cash Items soared 439.81% in 2022, then plummeted 98.76% in 2025.
  • Year by year, Non-cash Items stood at $74100.0 in 2021, then skyrocketed by 439.81% to $400000.0 in 2022, then crashed by 34.17% to $263330.0 in 2023, then grew by 22.8% to $323370.0 in 2024, then tumbled by 98.76% to $4000.0 in 2025.
  • Business Quant data shows Non-cash Items for PBSV at $4000.0 in Q4 2025, $323370.0 in Q4 2024, and $263330.0 in Q4 2023.